Outlook Therapeutics, Inc. Share Price
NASDAQ: OTLK | Micro CapOutlook Therapeutics, Inc. Stock Performance
Outlook Therapeutics, Inc. Share Price Today
As of 31 October 2026, Outlook Therapeutics, Inc.'s share price is $0.47. The stock opened at $0.49, compared to its previous close of $0.49. During today's trading session, Outlook Therapeutics, Inc.'s share price traded between $0.45 and $0.49, with an average price of $0.47. Over the past 52 weeks, the stock has recorded a high of $2.51 and a low of $0.16. In terms of performance, Outlook Therapeutics, Inc.'s share price has risen by 83.83% over the last six months and is down 63.38% on a year-on-year basis.
Outlook Therapeutics, Inc. Share Price Chart
Outlook Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Outlook Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Outlook Therapeutics, Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
Outlook Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $0.56 | $0.47 | -19.52% |
Sep 2026 | $0.63 | $0.58 | -9.67% |
Aug 2026 | $0.94 | $0.64 | -34.46% |
Jul 2026 | $1.49 | $0.98 | -38.88% |
Jun 2026 | $0.74 | $1.60 | +119.48% |
May 2026 | $0.26 | $0.73 | +188.14% |
Apr 2026 | $0.21 | $0.25 | +25.87% |
Mar 2026 | $0.43 | $0.20 | -52.48% |
Feb 2026 | $0.43 | $0.42 | -3.20% |
Jan 2026 | $0.64 | $0.44 | -72.34% |
Dec 2025 | $1.79 | $1.58 | -11.98% |
Nov 2025 | $1.27 | $1.79 | +41.34% |